Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
The RMR Group
RMR
$346M
| $4.47M | ﹤0.01% |
98,039
-7,277
| -7% | -$338K |
|
2077
Cass Information Systems
CASS
$750M
| $4.47M | ﹤0.01% |
77,404
+1,343
| +2% | +$75.2K |
|
2078
Titan Machinery
TITN
$420M
| $4.46M | ﹤0.01% |
301,675
+1,218
| +0.4% | +$19K |
|
|
ATRS
2079
DELISTED
Antares Pharma, Inc.
ATRS
| $4.46M | ﹤0.01% |
948,104
+1,926
| +0.2% | +$7.88K |
|
2080
Marcus Corp
MCS
$929M
| $4.45M | ﹤0.01% |
140,130
+2,592
| +2% | +$87.6K |
|
2081
Pacific Biosciences
PACB
$357M
| $4.45M | ﹤0.01% |
865,098
+17,401
| +2% | +$88.4K |
|
|
MOBL
2082
DELISTED
MobileIron, Inc.
MOBL
| $4.44M | ﹤0.01% |
914,129
-67,283
| -7% | -$358K |
|
2083
NovaGold Resources
NG
$3.4B
| $4.42M | ﹤0.01% |
493,816
+10,140
| +2% | +$70.2K |
|
2084
Veeco
VECO
$3.28B
| $4.41M | ﹤0.01% |
300,302
+115
| +0% | +$1.57K |
|
2085
Clear Channel Outdoor Holdings
CCO
$1.18B
| $4.41M | ﹤0.01% |
1,541,558
+29,831
| +2% | +$75.5K |
|
|
TGH
2086
DELISTED
Textainer Group Holdings limited
TGH
| $4.4M | ﹤0.01% |
410,625
+67,832
| +20% | +$661K |
|
|
DERM
2087
DELISTED
Dermira, Inc.
DERM
| $4.39M | ﹤0.01% |
289,551
+5,191
| +2% | +$44.8K |
|
2088
Horizon Bancorp
HBNC
$1.05B
| $4.39M | ﹤0.01% |
230,853
+4,219
| +2% | +$77.4K |
|
|
RVNC
2089
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.37M | ﹤0.01% |
269,359
+24,274
| +10% | +$376K |
|
2090
Arvinas
ARVN
$589M
| $4.35M | ﹤0.01% |
105,780
+28,101
| +36% | +$823K |
|
2091
QuinStreet
QNST
$1.19B
| $4.33M | ﹤0.01% |
283,097
+10,160
| +4% | +$145K |
|
|
WCN
2092
Waste Connections
WCN
$41.6B
| $4.31M | ﹤0.01% |
47,444
+1,235
| +3% | +$112K |
|
2093
Omeros
OMER
$1.26B
| $4.3M | ﹤0.01% |
305,027
+26,725
| +10% | +$391K |
|
2094
Dorian LPG
LPG
$1.95B
| $4.29M | ﹤0.01% |
277,217
+103,280
| +59% | +$1.36M |
|
|
GLUU
2095
DELISTED
Glu Mobile Inc.
GLUU
| $4.28M | ﹤0.01% |
707,958
+25,883
| +4% | +$148K |
|
2096
Fossil Group
FOSL
$330M
| $4.28M | ﹤0.01% |
543,051
+57,895
| +12% | +$534K |
|
2097
HealthStream
HSTM
$849M
| $4.28M | ﹤0.01% |
157,271
+2,882
| +2% | +$79.3K |
|
|
FLXN
2098
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $4.26M | ﹤0.01% |
205,956
+5,019
| +2% | +$84.6K |
|
2099
RE/MAX Holdings
RMAX
$265M
| $4.26M | ﹤0.01% |
110,601
-46,259
| -29% | -$1.66M |
|
2100
Camden National
CAC
$996M
| $4.25M | ﹤0.01% |
92,374
+704
| +0.8% | +$31.1K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.